Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 80

Clostridium butyricum for anxiety and depression in functional dyspepsia

Official title: Efficacy of Clostridium Butyricum in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia:A Prospective, Double-Blind, Randomized, Placebo-Controlled Clinical Trial

Run by Xijing Hospital of Digestive Diseases · NCT07182890 · Data updated 2026-11-12

This trial will test whether taking the probiotic Clostridium butyricum for four weeks can reduce anxiety and depression symptoms in adults with functional dyspepsia.

More Depression trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment180 (estimated)
SponsorXijing Hospital of Digestive Diseases
Academic / other
Locations1 site (Xi’an, Shanxi)
StatusRecruiting
StartedMarch 26, 2026
Main results expectedOctober 30, 2026
Study endsMay 31, 2027
Registry record updatedOctober 13, 2026
Trial IDNCT07182890 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–80 with Rome IV–diagnosed functional dyspepsia and HADS scores of 8–14 who are not pregnant, are H. pylori–negative, and have not used probiotics, antibiotics, or psychoactive medications in the prior month.

Probably not a fit

Patients with severe mood disorders (HADS outside 8–14), positive H. pylori, recent antibiotic or probiotic use, ongoing psychoactive medication, major comorbid GI disorders, pregnancy, or a history of substance abuse are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, double-blind Phase 4 trial will enroll 180 adults with functional dyspepsia (90 per group) who have mild-to-moderate anxiety or depression (HADS 8–14). All participants will continue conventional FD treatment while one group receives oral Clostridium butyricum and the other receives a matched placebo for four weeks. The primary outcome is change in Hospital Anxiety and Depression Scale (HADS) score after four weeks, with secondary outcomes likely including symptom and safety measures. The design excludes recent probiotic/antibiotic use, recent psychoactive medication, and H. pylori–positive patients to isolate the probiotic's effect on mood symptoms.

Why it matters

Potential benefit: If effective, the probiotic could offer a low-risk adjunct to standard FD care that reduces anxiety and depression symptoms.

How similar studies have gone: Prior probiotic studies and early research on gut–brain interactions have shown mixed but sometimes modest improvements in mood, while evidence specifically for Clostridium butyricum in this context is limited and preliminary.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients diagnosed with functional dyspepsia (FD) according to the Rome IV criteria.
* Aged 18 to 80 years, regardless of gender.
* Hospital Anxiety and Depression Scale (HADS) score between 8 and 14.

Exclusion Criteria:

* Use of probiotics or antibiotics within one month prior to the trial.
* Use of psychoactive medications (including hypnotics, sedatives, anxiolytics, or antidepressants) within one month prior to the trial.
* Use of hormones, immunosuppressants, or cytotoxic agents within one month prior to the trial.
* Participation in any other clinical trial within one month prior to the study.
* Positive test for Helicobacter pylori (Hp) infection.
* Long-term use of traditional Chinese herbal medicine.
* Pregnancy or lactation.
* History of drug abuse.
* Comorbidities such as irritable bowel syndrome (IBS), gastroesophageal reflux disease (GERD), functional constipation (FC), or other significant conditions that may interfere with the trial-including severe hepatic, renal, respiratory, or autoimmune disorders; bleeding diatheses; psychiatric diseases; endocrine disorders; etc.
* History of major surgery or diagnosis of diabetes mellitus.
* Refusal to provide written informed consent.

Where it's running

  • Air Force Medical University
    Xi’an, Shanxi, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.